更正：透析前慢性肾脏病中的肌少症肥胖：在一项为期六年的前瞻性队列研究中，肌肉力量是死亡率和疾病进展的预测指标。
Correction: Sarcopenic obesity in predialysis chronic kidney disease: Muscle strength is a predictor of mortality and disease progression in a six-year prospective cohort.
出版信息
PLoS One. 2025 Sep 12;20(9):e0332435. doi: 10.1371/journal.pone.0332435. eCollection 2025.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0318773.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0318773。]
相似文献
1
Correction: Sarcopenic obesity in predialysis chronic kidney disease: Muscle strength is a predictor of mortality and disease progression in a six-year prospective cohort.更正：透析前慢性肾脏病中的肌少症肥胖：在一项为期六年的前瞻性队列研究中，肌肉力量是死亡率和疾病进展的预测指标。
PLoS One. 2025 Sep 12;20(9):e0332435. doi: 10.1371/journal.pone.0332435. eCollection 2025.
2
Sarcopenic obesity in predialysis chronic kidney disease: Muscle strength is a predictor of mortlity and disease progression in a six-year prospective cohort.透析前慢性肾脏病患者的肌少症性肥胖：在一项为期六年的前瞻性队列研究中，肌肉力量是死亡率和疾病进展的预测指标。
PLoS One. 2025 Mar 18;20(3):e0318773. doi: 10.1371/journal.pone.0318773. eCollection 2025.
3
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis.重组人促红细胞生成素与安慰剂或不治疗对非透析依赖型慢性肾脏病患者贫血的疗效比较
Cochrane Database Syst Rev. 2016 Jan 20;2016(1):CD003266. doi: 10.1002/14651858.CD003266.pub3.
4
Association between sarcopenic obesity and the risk of knee osteoarthritis in the middle-aged and elderly Chinese population: A 7-year cohort study.中国中老年人群中肌肉减少性肥胖与膝关节骨关节炎风险的关联：一项7年队列研究
Clin Nutr ESPEN. 2025 Aug;68:575-582. doi: 10.1016/j.clnesp.2025.06.002. Epub 2025 Jun 6.
5
Low Hand Grip Strength Is Associated with Increased Risk of Cognitive Impairment in Older Men, Including Men with Probable Sarcopenic Obesity: Results from the Northern Ireland PRIME-COG Cohort.
Gerontology. 2025 Jul 11:1-12. doi: 10.1159/000547314.
6
The Diagnosis and Treatment of Sarcopenia and Sarcopenic Obesity.肌少症和肌少症肥胖症的诊断与治疗
Dtsch Arztebl Int. 2025 Mar 7;122(5):121-126. doi: 10.3238/arztebl.m2025.0004.
7
The prevalence of sarcopenia and sarcopenic obesity in a German geriatric day clinic.德国一家老年日间诊所中肌肉减少症和肌肉减少性肥胖症的患病率。
J Frailty Aging. 2025 Sep 6;14(5):100072. doi: 10.1016/j.tjfa.2025.100072.
8
Sarcopenic obesity and risk of cardio-cerebrovascular disease and mortality: a systematic review and meta-analysis.肌少性肥胖与心脑血管疾病及死亡率风险：一项系统评价与荟萃分析
Int J Obes (Lond). 2025 Sep 15. doi: 10.1038/s41366-025-01909-z.
9
Benefits and side effects of protein supplementation and exercise in sarcopenic obesity: A scoping review.补充蛋白质和运动对肥胖型肌少症的益处和副作用：范围综述。
Nutr J. 2023 Oct 23;22(1):52. doi: 10.1186/s12937-023-00880-7.
10
Associations of sarcopenia, sarcopenia components and sarcopenic obesity with cancer incidence: A prospective cohort study of 414,094 participants in UK Biobank.肌肉减少症、肌肉减少症组成部分及肌肉减少性肥胖与癌症发病率的关联：对英国生物银行414,094名参与者的一项前瞻性队列研究。
Int J Cancer. 2025 Oct 1;157(7):1316-1332. doi: 10.1002/ijc.35480. Epub 2025 May 21.
本文引用的文献
1
Sarcopenic obesity in predialysis chronic kidney disease: Muscle strength is a predictor of mortlity and disease progression in a six-year prospective cohort.透析前慢性肾脏病患者的肌少症性肥胖：在一项为期六年的前瞻性队列研究中，肌肉力量是死亡率和疾病进展的预测指标。
PLoS One. 2025 Mar 18;20(3):e0318773. doi: 10.1371/journal.pone.0318773. eCollection 2025.
Zotero 插件